Results 201 to 210 of about 28,157 (212)

Efficacy and Safety of mRNA-Based COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
Alkhidir M, Sridharan K.
europepmc   +1 more source

Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study. [PDF]

NPJ Vaccines
Bergmann JS, Hamm SR, Bering L, Pedersen CR, Bock A, Heidari SL, Villadsen GE, Fialla AD, Willemoe GL, Holland-Fischer P, Nielsen SD.   +10 more
europepmc   +1 more source

BNT162b2 COVID-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5-11 years in Scotland. [PDF]

J Glob Health
Rudan I, Kerr S, Sullivan C, Jeffrey K, Grange Z, Fenton L, Kurdi A, Shi T, Cullen L, Simpson CR, Katikireddi SV, Ritchie LD, Robertson C, Sheikh A.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Decreased Infectivity Following BNT162b2 Vaccination

SSRN Electronic Journal, 2021
Background: BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine’s effect on infectivity is thus a critical priority. Methods: In a cohort of all 9650 HCW of a large single tertiary medical center, we calculated the ...
Gili Regev-Yochay, Sharon Amit, Moriah Bergwerk, Marc Lipsitch, Eyal Leshem, Rebecca Kahn, Yaniv Lustig, Carmit Cohen, Ram Doolman, Arnona Ziv, Ilya Novikov, Carmit Rubin, Irena Gimpelevich, Amit Huppert, Galia Rahav, Arnon Afek, Yitshak Kreiss   +16 more
openaire   +1 more source

BNT162b2 Immunogenicity Among Patients Receiving Methotrexate

D102. TOPICS IN BEHAVIORAL SCIENCE AND HEALTH SERVICE RESEARCH, 2022
A. Petralia, R. Kashyap, K. Patel
openaire   +1 more source

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine, 2022
Andrea, Tumminia, Marcello, Romano
openaire   +2 more sources

Skin reaction following SARS-CoV-2 vaccine BNT162b2

Italian Journal of Dermatology and Venereology, 2023
Russo F., Santi F., Sirchio A., Lazzeri L., DE Piano E., Taddeucci P., Rubegni P.   +6 more
openaire   +4 more sources